Physician profile
Gene Rosenberg
NPI 1093716219
$677.42
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $93.93 · 2021: $111.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $172.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.59 | 2019-2020 | |
| Pfizer INC. | $75.92 | 2019-2021 | |
| Procept Biorobotics Corporation | $47.98 | 2019 | |
| Janssen Biotech, INC. | $43.90 | 2019-2021 | |
| Myovant Sciences INC. | $27.57 | 2021 | |
| Endo Pharmaceuticals INC. | $25.58 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.05 | 2019 | |
| Coloplast Corp | $22.34 | 2019 | |
| Rochester Medical Corporation | $15.07 | 2019 | |
| Abbvie INC. | $15.00 | 2019 | |
| Antares Pharma, INC. | $14.78 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $14.50 | 2019 | |
| Myriad Genetic Laboratories, INC. | $14.18 | 2021 | |
| Aytu Biopharma, INC. | $13.55 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $13.41 | 2019 | |
| Dendreon Pharmaceuticals LLC | $13.04 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $12.74 | 2019 | |
| 180 Medical, INC. | $12.51 | 2021 | |
| Ferring Pharmaceuticals INC. | $11.29 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.